Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 4 studies | 23% ± 9% | |
epithelial cell | 4 studies | 27% ± 10% |
Insufficient scRNA-seq data for expression of ASF1A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1251.01 | 2642 / 2642 | 100% | 48.80 | 705 / 705 |
ovary | 100% | 924.70 | 180 / 180 | 100% | 22.80 | 430 / 430 |
prostate | 100% | 647.29 | 245 / 245 | 100% | 23.91 | 502 / 502 |
esophagus | 100% | 715.69 | 1444 / 1445 | 100% | 26.79 | 183 / 183 |
breast | 100% | 654.98 | 459 / 459 | 100% | 32.85 | 1117 / 1118 |
thymus | 100% | 908.51 | 653 / 653 | 100% | 39.60 | 603 / 605 |
lung | 100% | 801.45 | 576 / 578 | 100% | 30.58 | 1154 / 1155 |
uterus | 100% | 782.45 | 170 / 170 | 100% | 27.11 | 457 / 459 |
bladder | 100% | 816.86 | 21 / 21 | 99% | 25.08 | 499 / 504 |
adrenal gland | 100% | 988.68 | 258 / 258 | 99% | 27.41 | 227 / 230 |
stomach | 100% | 654.61 | 359 / 359 | 99% | 21.20 | 282 / 286 |
pancreas | 99% | 450.84 | 325 / 328 | 99% | 15.81 | 177 / 178 |
intestine | 100% | 702.16 | 966 / 966 | 98% | 22.05 | 515 / 527 |
kidney | 100% | 551.87 | 89 / 89 | 97% | 16.02 | 872 / 901 |
liver | 99% | 405.00 | 223 / 226 | 97% | 15.84 | 395 / 406 |
skin | 100% | 798.58 | 1806 / 1809 | 89% | 17.09 | 420 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.09 | 29 / 29 |
spleen | 100% | 837.59 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.45 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.76 | 1 / 1 |
adipose | 100% | 604.24 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 648.24 | 801 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 714.55 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 645.05 | 837 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 79% | 12.72 | 63 / 80 |
peripheral blood | 74% | 477.54 | 687 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0140861 | Biological process | DNA repair-dependent chromatin remodeling |
GO_0006335 | Biological process | DNA replication-dependent chromatin assembly |
GO_0031297 | Biological process | replication fork processing |
GO_0006281 | Biological process | DNA repair |
GO_0006334 | Biological process | nucleosome assembly |
GO_0042692 | Biological process | muscle cell differentiation |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0140713 | Molecular function | histone chaperone activity |
GO_0042393 | Molecular function | histone binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | ASF1A |
Protein name | Histone chaperone ASF1A (Anti-silencing function protein 1 homolog A) (hAsf1) (hAsf1a) (CCG1-interacting factor A) (CIA) (hCIA) |
Synonyms | CGI-98 HSPC146 |
Description | FUNCTION: Histone chaperone that facilitates histone deposition and histone exchange and removal during nucleosome assembly and disassembly . Cooperates with chromatin assembly factor 1 (CAF-1) to promote replication-dependent chromatin assembly and with HIRA to promote replication-independent chromatin assembly . Promotes homologous recombination-mediated repair of double-strand breaks (DSBs) at stalled or collapsed replication forks: acts by mediating histone replacement at DSBs, leading to recruitment of the MMS22L-TONSL complex and subsequent loading of RAD51 . Also involved in the nuclear import of the histone H3-H4 dimer together with importin-4 (IPO4): specifically recognizes and binds newly synthesized histones with the monomethylation of H3 'Lys-9' and acetylation at 'Lys-14' (H3K9me1K14ac) marks, and diacetylation at 'Lys-5' and 'Lys-12' of H4 (H4K5K12ac) marks in the cytosol . Required for the formation of senescence-associated heterochromatin foci (SAHF) and efficient senescence-associated cell cycle exit . . |
Accessions | Q9Y294 ENST00000229595.6 |